Showing 1 - 5 results of 5 for search 'David Sarrio', query time: 0.03s
Refine Results
-
1
Novel Therapies and Strategies to Overcome Resistance to Anti-HER2-Targeted Drugs by Manuel Gámez-Chiachio, David Sarrió, Gema Moreno-Bueno
Published 2022-09-01
Article -
2
Gasdermin-B Pro-Tumor Function in Novel Knock-in Mouse Models Depends on the in vivo Biological Context by David Sarrio, David Sarrio, Alejandro Rojo-Sebastián, Ana Teijo, María Pérez-López, María Pérez-López, Eva Díaz-Martín, Lidia Martínez, Lidia Martínez, Saleta Morales, Saleta Morales, Pablo García-Sanz, José Palacios, José Palacios, Gema Moreno-Bueno, Gema Moreno-Bueno, Gema Moreno-Bueno
Published 2022-02-01
Article -
3
Evaluation of <i>ERBB2</i> mRNA Expression in HER2-Equivocal (2+) Immunohistochemistry Cases by Irene Carretero-Barrio, Tamara Caniego-Casas, Marta Rosas, María Concepción Sánchez, Noelia Martínez-Jáñez, Miguel Chiva, David Sarrió, Gema Moreno-Bueno, José Palacios, Belén Pérez-Mies
Published 2023-03-01
Article -
4
MicroRNA-200 family modulation in distinct breast cancer phenotypes. by María Ángeles Castilla, Juan Díaz-Martín, David Sarrió, Laura Romero-Pérez, María Ángeles López-García, Begoña Vieites, Michele Biscuola, Susana Ramiro-Fuentes, Clare M Isacke, José Palacios
Published 2012-01-01
Article -
5
Gasdermin B over-expression modulates HER2-targeted therapy resistance by inducing protective autophagy through Rab7 activation by Manuel Gámez-Chiachio, Ángela Molina-Crespo, Carmen Ramos-Nebot, Jeannette Martinez-Val, Lidia Martinez, Katja Gassner, Francisco J. Llobet, Mario Soriano, Alberto Hernandez, Marco Cordani, Cristina Bernadó-Morales, Eva Diaz, Alejandro Rojo-Sebastian, Juan Carlos Triviño, Laura Sanchez, Ruth Rodríguez-Barrueco, Joaquín Arribas, David Llobet-Navás, David Sarrió, Gema Moreno-Bueno
Published 2022-09-01
Article